Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
biotech
boston blog main
5
×
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
5
×
detroit blog main
detroit top stories
glaxosmithkline
5
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
5
×
texas blog main
5
×
texas top stories
wisconsin blog main
wisconsin top stories
cancer
eli lilly
fda
alzheimer's disease
amgen
bristol-myers squibb
cancer immunotherapy
deals
merck
abbvie
What
roundup
bio
black
companies
diamond’s
nash
news
according
akcea
alliance
appetite
approval
biogen’s
biopharmaceutical
biotech
bread
bristol
butter
buy
buyout
calls
cancer
cases
cash
centers
changing
cigarettes
color
continue
control
convo
crispr
days
deaths
debut
diabetes
diamond
disease
drug
drugs
Language
unset
Current search:
glaxosmithkline
×
startups
×
" texas blog main "
×
photo
×
" clinical trials "
×
" boston blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More